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Abstract
Background:  Pneumococcal disease causes significant morbidity and mortality in at-risk
individuals, and is complicated by emerging antibiotic resistance. An effective, safe and cost-effective
vaccine is available, but despite this many patients who would benefit from pneumococcal
vaccination remain unvaccinated. The purpose of this study was to determine the rates of missed
opportunities to provide pneumococcal vaccination to patients being discharged from a tertiary
center medical teaching unit and to determine if a nurse coordinator-based intervention would
increase rates of pneumococcal vaccination prior to discharge home.
Methods: We conducted a prospective, controlled study in the setting of a Medical Teaching Unit
at a tertiary care centre to assess the impact of a nurse coordinator based intervention on the rates
of vaccination of eligible patients on discharge home. The rates of vaccination during an eight-week
usual-care period (February 20 to April 16, 2002) and an eight-week intervention period (April 22
to June 16, 2002) were compared.
Results: Prior to the intervention none of thirty-eight eligible patients were vaccinated prior to
discharge home from the Medical Teaching Unit. After the intervention 27 (54%) of fifty eligible
patients were vaccinated prior to discharge.
Conclusion: There are significant missed opportunities to provide pneumococcal vaccination to
inpatients who are discharged home from a medical unit. Using a patient care coordinator we were
able to significantly improve the rates of vaccination on discharge.
Background
Invasive infection by streptococcus pneumoniae is an impor-
tant cause of morbidity and mortality, particularly in indi-
viduals older than 65 years of age, and those with chronic
health conditions. The incidence of invasive pneumococ-
cal disease almost triples in those over 65. Despite appro-
priate antibiotic therapy and supportive care there is a
high case fatality rate in pneumococcal bacteremia of 15–
20% in adults overall with highest rates in those over 65
and those with chronic medical conditions. The case fatal-
ity rate has been reported as 12.1% for individuals aged
16 to 64 with indications for vaccination compared to
5.4% to individuals of the same age with no indications
[1].
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Previously there was uniform susceptibility to penicillins.
The National Centre for Streptococcus in Edmonton,
Alberta now has reported 10.2% of isolates have dimin-
ished susceptibility to penicillin [2]. Macrolide resistance
among invasive S. pneumoniae isolates also dramatically
increasing [3].
Given the high morbidity and mortality of pneumococcal
disease, and increasing antibiotic resistance, the focus is
shifting to primary prevention. The 23-valent pneumo-
coccal vaccine is between 50–80% effective against inva-
sive pneumococcal disease in older and high-risk
individuals [4]. The vaccine is also cost-effective in high-
risk individuals [5,6].
The rates of vaccination against pneumococcus are well
below targets and studies have shown significant missed
opportunities for vaccination of at-risk individuals [7].
The Health Canada target vaccination rate is 80% of
patients who meet the Canadian Immunization Guide-
lines criteria for pneumococcal vaccination [8]. However,
only 42% of those over 65 and 15% of those eligible per-
sons younger than 65 have received pneumococcal vacci-
nation [8]. Studies have shown that 36% to 70% of
patients admitted to hospital with invasive pneumococcal
infection had been inpatients in the five years prior to
admission [9,10]. Brull et al demonstrated that pneumo-
coccal vaccine is the most commonly overlooked preven-
tive health intervention among medial patients who are
discharged from a tertiary care hospital [11]. Another
study showed that a computerized reminder system in a
teaching hospital resulted in a pneumococcal vaccination
rate of 35.8% of eligible patients compared to 0.8% in the
control group [12]. Many hospitals do not have special-
ized computer systems such as that described in this
study, therefore the generalizability of the study is limited.
Given the evidence that there was room for improvement
in the delivery of pneumococcal vaccination to at-risk
individuals discharged from hospital, we embarked on a
study to determine if a nurse-coordinator-based interven-
tion would increase the rate of pneumococcal vaccination
of eligible patients discharged home from an inpatient
medical teaching unit.
Methods
Our study was conducted on the medical teaching unit
(MTU) at Foothills Medical Centre, a tertiary referral cen-
tre in Calgary, Canada with over 700 inpatient beds. The
MTU had an average patient census of 20 to 30 with a
median length of stay of 7 days. Primary medical care was
provided by 3 to 4 clinical clerks and 4 to 5 junior resi-
dents under the supervision of 2 senior residents and an
attending physician. The team also had a dedicated clini-
cal pharmacist and a care coordinator. The care coordina-
tor is a registered nurse who routinely meets with patients
on the day of admission to describe the structure of the
MTU, liaises with the patient's outpatient primary care
and specialist physicians and coordinates appropriate
resources and follow-up for the patient on discharge from
hospital.
Patients were considered to be eligible for our study if they
met Canadian Immunization Guidelines criteria to
receive pneumococcal vaccination, these criteria are
described in Appendix 1 [8]. Patients who died, were
transferred to other services or had been vaccinated prior
to admission were excluded. Patients transferred to other
services included those transferred to critical care services
and surgical services for surgical intervention. Medically
stable patients for which a protracted hospitalization was
anticipated were transferred to a non-teaching service
prior to discharge home or to long term care facilities.
The first admission was used for patients admitted multi-
ple times to the medical teaching unit. Patients admitted
during the usual-care period were eligible to be included
in the intervention period if they continued to meet eligi-
bility criteria.
Previous vaccination status was determined by asking the
patient and by reviewing the Calgary Public Health vacci-
nation database, which includes information on all pneu-
mococcal vaccinations given in the Calgary Health Region
since 1997.
At the outset of the study a multidisciplinary team com-
prised of internal medicine residents, attending internists,
an MTU Care Coordinator, a pharmacist, a nurse manager
and a representative from public health was assembled.
The team noted that there was no process in place to
ensure that eligible patients would be vaccinated on dis-
charge. They embarked on the task of developing a flow-
chart that would represent a rational process that, if
followed, would result in vaccination of patients who
were discharged home from the MTU.
The final process is diagrammed in Figure 1.
The final study consisted of a pre and post intervention
where an assessment of pneumococcal vaccine provision
on discharge home took place during a usual care period
and then an intervention period where the process
described in figure 1 and outlined below in the 'Interven-
tion Period' was implemented.
Usual-care period
The usual care period consisted of an eight-week period
where the medical students and residents on the MTU
were provided with a standardized form outliningBMC Public Health 2005, 5:110 http://www.biomedcentral.com/1471-2458/5/110
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eligibility for pneumococcal vaccination. These team
members were responsible for assessment of patient eligi-
bility, determining vaccination status and, if appropriate,
ordering a dose of vaccine. However, no advice on how
best to carry out these tasks was provided. The MTU Care
Coordinator determined vaccine eligibility and gathered
information on previous vaccination status and whether
or not a vaccine dose was ordered at the time a patient was
discharged from hospital. This information was not pro-
vided to the medical students or residents. The usual care
period extended from February 20 to April 16, 2002.
Intervention period
The intervention period involved rolling out the process
described above and outlined in Figure 1. The first step in
the process included a formalized method of
The study algorithm for vaccinating patients discharged during the usual-care and intervention periods Figure 1
The study algorithm for vaccinating patients discharged during the usual-care and intervention periods.
USUAL CARE INTERVENTION
Admit patient to MTU 
Identify if eligible for pneumococcal vaccine
(resident or nurse coordinator) 
Determine if vaccinated (nurse coordinator with 
public health)
Educate patient and offer vaccine (resident, staff
nurse and nurse coordinator)
Order vaccine (resident or nurse coordinator)
Administer vaccine and inform pharmacy of 
vaccination (staff nurse)
Inform public health of vaccination (pharmacy)
Record date of vaccination in chart and patient 
information system (staff nurse) 
Discharge patient
Admit patient to MTU 
Discharge patientBMC Public Health 2005, 5:110 http://www.biomedcentral.com/1471-2458/5/110
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identification of eligible patients. A standardized eligibil-
ity form was developed and a consistent individual, the
MTU care coordinator, was given the responsibility of
ensuring that the form was completed. The completed eli-
gibility form was faxed to the public health office where
the database was examined and the vaccination status of
the patients admitted to the MTU was reported to the
MTU care coordinator. Patients who were eligible to
receive the pneumococcal vaccine but had not been previ-
ously vaccinated were provided with educational materi-
als on the vaccine by the MTU care coordinator who
would, in concert with the floor nurses, housestaff and the
attending internist, answer any patient questions on the
vaccine. The patient was then offered the vaccine and, if
they agreed, it was ordered by the housestaff on the team.
The MTU care coordinator oversaw this process and
would ensure that the responsible housestaff ordered the
vaccine. Nursing staff administered the vaccine as ordered
and completed a vaccination form that was sent to the
pharmacy. The pharmacy would forward these forms on
to public health so that the vaccination database could be
updated. All of the individuals and procedures described
The flow of patients in the intervention and usual care periods of the study Figure 2
The flow of patients in the intervention and usual care periods of the study.
Usual Care  Intervention
Patients admitted 108 121
20 not 
eligible for 
vaccine
23 not 
eligible for 
vaccine
85 101
61 74
24 previously 
vaccinated
Final study 
population
Patients not 
previously
vaccinated
Eligible patients
24 died or 
were
transferred to 
other services
50
27 previously 
vaccinated
23 died or were
transferred to 
other services
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above were present prior to the intervention but were not
previously linked together by a responsible individual –
the care coordinator.
A nursing inservice was held on April 17, 2002 to inform
staff of the initiative, the background issues and to review
vaccine administration and charting. At this time the vac-
cination rates from the initial 8 week assessment were
posted for nursing staff and residents. On April 22, 2002
a computerized message appeared on terminals through-
out the Foothills Medical Centre reminding staff to vacci-
nate eligible patients against pneumococcus on discharge.
From April 22 to June 16, 2002 the process described
above was implemented.
Statistical analysis
The overall characteristics of patients admitted to the
MTU and those for the usual-care and the intervention
period were described using means or medians for contin-
uous variables and proportions for categorical variables.
Differences between the groups were assessed using Stu-
dent's t-test. The vaccination rates during the study period
were compared using the Chi-square test. All analyses
were carried out using Stata Version 5 [13].
Results
The final study population consisted of 38 individuals in
the usual-care group and 50 individuals in the interven-
tion group (Figure 2). There were 229 individuals admit-
ted to the MTU during the two eight-week study periods
(108 in the usual-care period and 121 during the interven-
tion period). Eight individuals had multiple admissions.
Of the patients admitted to the MTU 80.8% (n = 186)
were eligible to receive pneumococcal vaccine. Ninety-
one (48.9%) of patients were eligible because they were
aged greater than 65 years. For patients less than 65 years
of age the most common reason for eligibility was liver
disease 45.3% (n = 43). Fifty-one (27.4%) of the individ-
uals who met criteria for vaccination had been vaccinated
prior to admission, 15.7% of the patients less than 65
years of age and 39.6% of the greater than 65 years age
group, and were, therefore excluded from the final study
population. Sixty-five percent of eligible patients who
were not previously vaccinated were discharged home
leaving a final study population of 88 patients.
The characteristics of the final study population by inter-
vention group are described in Table 1. The study popula-
tion was similar prior to and during the intervention with
no significant difference between the two groups with
respect to age, length of stay or sex. The primary study out-
come was vaccination rate on discharge home. Fifty-four
percent (n = 27) of patients in the intervention group were
vaccinated prior to discharge home compared to none of
the patients in the usual-care group. The vaccination rate
for individuals greater than 65 years of age tended to be
higher than the younger group (64.7% versus 48.5%).
However, this difference was not statistically significant (p
= 0.276). Individuals vaccinated on discharge also had a
longer median length of stay (5.5 versus 10 days) but the
interquartile ranges for these two values overlap (i.e. the
difference was not statistically significant).
To determine if the study had a broader impact on pre-
scribing of pneumococcal vaccines in the Foothills Hospi-
tal, we examined ordering of pneumococcal vaccine
outside of the MTU setting. In addition to the 27 patients
vaccinated on the MTU, 73 patients were vaccinated on
other services. Vaccine use was assessed in the same time
periods as the study in the year prior to and after the study.
There was an increase from 13 vaccinations in 2001 to
219 in 2003 while the Foothills hospital bed capacity
Table 1: Characteristics of study population
Characteristic Usual-care (n = 38) Intervention (n = 50)
Age (mean with 95% CI) 56.1 (50.9–61.2) 54.7 (49.7–59.6)
<65 years of age % (n) 63.2% (24) 66% (33)
Reason for vaccine eligibility if age < 65 years*
Splenectomy 1.5% (1) 3.0% (1)
Cardiovascular disease 15.4% (10) 6.1% (2)
Pulmonary disease 13.9% (9) 6.1% (2)
Liver disease (includes alcoholism) 30.8% (20) 51.5% (17)
Renal disease 4.6% (3) 9.1% (3)
Diabetes mellitus 16.9% (11) 24.2% (8)
Immunosuppressed 6.2% (4) 24.2% (8)
Length of stay (median with IQ range) 7 (3–14) days 7 (4–11) days
Female (%) 52.6% (20) 38.0% (19)
*percentages add up to more than 100 because individuals are present in more than one categoryBMC Public Health 2005, 5:110 http://www.biomedcentral.com/1471-2458/5/110
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increased by only 36 beds (April 2001 761 beds, April
2002 766 beds and April 2003 797 beds). This informa-
tion is presented in Figure 3.
Discussion
We demonstrated that there are significant missed oppor-
tunities to provide pneumococcal vaccination to eligible
patients discharged home from a medical teaching unit
service. Further, we demonstrated that by a collaborative,
multidisciplinary effort and with the involvement of a
nurse coordinator, we were able to assess 100% of
patients for eligibility and reach a vaccination rate of 54%
[14,15]. Additionally, one year after the intervention the
use of pneumococcal vaccine remains increased com-
pared to prior to this study. The successful intervention
involved developing a sustainable process for vaccinating
patients on discharge by reorganizing existing resources.
The vaccination rate in this study was superior to that
which is currently achieved on an outpatient basis. Fur-
thermore, it was also superior to the improvement that
was shown in a recent study assessing the impact of a
highly specialized computerized reminder system that
found a rate of 35.8% after their intervention suggesting
that a multimodality intervention is superior to ensure
vaccination on discharge [12]. Other interventions that
utilized computer-generated admissions list and pre-
printed order forms for the vaccine and a dedicated nurse
vaccine manager did not manage to achieve rates of vacci-
nation as high as that which was reached in our study. We
think the superior results achieved in our study stem from
the systematic process developed using integral team
members to ensure vaccination on discharge and there
being a single responsible individual being accountable.
Based on the known efficacy of the vaccine, and its cost
effectiveness in high risk populations, we would antici-
pate that this intervention will diminish invasive
pneumococcal disease, hospitalizations and health care
costs in the future.
One limitation in this study was vaccine supply. The hos-
pital pharmacy had anticipated an increase in vaccine uti-
lization. However, the degree of increased vaccine
ordering far exceeded that which was anticipated and
there was a one week time period when patients were una-
ble to receive vaccination prior to discharge due to lack of
availability. A further limitation was that occasionally
patients were discharged and left hospital prior to receiv-
ing an ordered vaccination. We were unable to quantify
the number of theses cases. The continuity of a nurse coor-
dinator in the setting of a MTU where housestaff are
constantly rotating was pivotal, and this approach will be
most applicable on services where there is a nurse care
coordinator. A strength of our study was the presence of a
population-based database of vaccination. This database
allowed the intervention to taget unvaccinated patients.
Without the database 27% of patients entering the hospi-
tal could have been revaccinated.
A meta-analysis of interventions that increase adult
immunization supports organizational change as the
most effective means of improving preventive care meas-
ures, surpassing financial incentives, patient reminders,
patient education and feedback [16]. We found also that
organizational change, with the involvement of a nurse
coordinator to do specific prevention activities was effec-
tive. With the flux of staff on the MTU the long-term sus-
tainability of this intervention remains to be proven.
Conclusion
There are significant missed opportunities to provide
pneumococcal vaccination to hospital inpatients who are
at high risk from pneumococcal pneumonia. The use of a
patient care coordinator and minor system changes signif-
icantly improved the rates of vaccination on discharge.
Pneumococcal vaccination use in Foothills Hospital* Figure 3
Pneumococcal vaccination use in Foothills Hospital*. * The 
number of vaccinations administered in the Foothills Hospital 
prior to and following the study. The time periods were cho-
sen to correspond with the study periods in 2002 – usual-
care period from Feb. 20 to April 16 and the intervention 
period from April 22 to June 16. The bar graph shows an 
increase in administration of pneumococcal vaccinations after 
the intervention and indicating there were significant effects 
outside of the unit where the intervention occurred and that 
the effect was sustained after the study was terminated.
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List of abbreviations
MTU: Medical teaching Unit
Appendix
Guidelines for use of pneumococcal vaccination [7].
• All persons ≥65 years of age
• All persons >2 years with the following: asplenia, splenic
dysfunction or sickle cell disease
• All persons >2 years with the following chronic condi-
tions: chronic cardiorespiratory disease (except asthma),
cirrhosis, alcoholism, chronic renal disease, nephritic syn-
drome, diabetes mellitus, chronic CSF leak, HIV infection
and other conditions associated with immunosuppres-
sion (Hodgkins disease, lymphoma, multiple myeloma,
induced immunosuppression for organ transplantation
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